COMMUNIQUÉ DE PRESSE publié le 17/08/2026 à 16:52, il y a 24 jours 17 heures Algorhythm Holdings Reports Second Quarter 2026 Financial Results Fort Lauderdale, FL, USA, August 17th, 2026, FinanceWire
COMMUNIQUÉ DE PRESSE publié le 17/08/2026 à 16:11, il y a 24 jours 17 heures Genius Monkey Launches In-Play CTV for Live Sports Streaming Tempe, Arizona, August 17th, 2026, FinanceWire
COMMUNIQUÉ DE PRESSE publié le 17/08/2026 à 16:05, il y a 24 jours 17 heures Mavrix Makes the Case for Trusted Human Evidence in the AI Era at Quirk's New York Mavrix emphasizes the importance of human evidence in the AI era at Quirk's New York event, highlighting the value of reaching, verifying, and engaging real people Data Intelligence AI Era Mavrix Human Evidence Quirk's New York
COMMUNIQUÉ DE PRESSE publié le 17/08/2026 à 15:50, il y a 24 jours 18 heures Investment Management Enters the Autonomous Era New York, USA, August 17th, 2026, FinanceWire
COMMUNIQUÉ DE PRESSE publié le 17/08/2026 à 15:44, il y a 24 jours 18 heures JOST Werke SE begins trading on OTCQX® Best Market in the United States JOST Werke SE begins trading on OTCQX Best Market in the United States, expanding access for U.S. investors while retaining Frankfurt Stock Exchange listing Frankfurt Stock Exchange JOST Werke SE United States U.S. Investors OTCQX Best Market
COMMUNIQUÉ DE PRESSE publié le 17/08/2026 à 15:25, il y a 24 jours 18 heures Form 8.3 - The Vanguard Group, Inc.: AEW UK REIT plc The Vanguard Group, Inc. discloses a 1.02% stake in AEW UK REIT plc as of 14 August 2026 according to Form 8.3 under the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure AEW UK REIT Plc
COMMUNIQUÉ DE PRESSE publié le 17/08/2026 à 15:24, il y a 24 jours 18 heures Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5% interest in Beazley plc's 5p ordinary securities on 14 August 2026 per Form 8.3 under the Takeover Code Securities Form 8.3 Takeover Code Vanguard Group Beazley Plc
COMMUNIQUÉ DE PRESSE publié le 17/08/2026 à 15:23, il y a 24 jours 18 heures Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc The Vanguard Group, Inc. discloses a 5.68% interest in Intertek Group plc. Purchase and sale of 1p ordinary securities on 14-Aug-2026 Disclosure Vanguard Group Inc. Purchase Sale Intertek Group Plc
COMMUNIQUÉ DE PRESSE publié le 17/08/2026 à 15:22, il y a 24 jours 18 heures Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc. The Vanguard Group, Inc. files disclosure related to Prologis, Inc. under Rule 8.3 of the Takeover Code. Ownership interests revealed Disclosure Rule 8.3 Takeover Code Vanguard Group Prologis Inc.
COMMUNIQUÉ DE PRESSE publié le 17/08/2026 à 15:21, il y a 24 jours 18 heures Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.72% ownership in Schroders plc with 43,757,023 securities. Form 8.3 submitted on 14 Aug 2026 Securities Form 8.3 Schroders Plc Vanguard Group Ownership Disclosure
Publié le 11/09/2026 à 07:00, il y a 2 heures 54 minutes Transparantiekennisgeving van Baltisse Groep
Publié le 11/09/2026 à 07:00, il y a 2 heures 54 minutes BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Publié le 11/09/2026 à 07:00, il y a 2 heures 54 minutes BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Publié le 10/09/2026 à 19:30, il y a 14 heures 24 minutes Availability of the 2026 Interim Financial Report
Publié le 11/09/2026 à 04:00, il y a 5 heures 54 minutes Torq Announces Debt Settlement and Corporate Update
Publié le 10/09/2026 à 22:25, il y a 11 heures 29 minutes Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Publié le 10/09/2026 à 15:20, il y a 18 heures 34 minutes MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Publié le 10/09/2026 à 15:00, il y a 18 heures 54 minutes All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Publié le 11/09/2026 à 09:20, il y a 34 minutes Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Publié le 11/09/2026 à 09:05, il y a 49 minutes ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Publié le 11/09/2026 à 09:00, il y a 54 minutes Homann Holzwerkstoffe publishes its 2026 half-year report